Concepedia

James W. Clendening

JW

Statistics

Publications

7

Citations

951

H-Index

7

Active since

2007

Affiliations

Ontario Institute for Cancer Research(Current)

University of Toronto

Princess Margaret Cancer Centre

Cancer Institute (WIA)

University Health Network

James W. Clendening is an author at Ontario Institute for Cancer Research specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2007–2013

7

Publications

7

Dysregulation of the mevalonate pathway promotes transformation

James W. Clendening, Aleks Pandyra, Paul C. Boutros et al. · Proceedings of the National Academy of Sciences · 2010 · 406 citations · Full text

, , +19

Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance

James W. Clendening, Carolyn A. Goard, Linda Z. Penn · BMC Cancer · 2010 · 163 citations · Full text

Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma

James W. Clendening, Aleksandra A. Pandyra, Zhihua Li et al. · Blood · 2010 · 99 citations · Full text

Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma

W. Wei‐Lynn Wong, James W. Clendening, Paul C. Boutros et al. · Molecular Cancer Therapeutics · 2007 · 79 citations · Full text

<i>CUL7</i> Is a Novel Antiapoptotic Oncogene

Sam S. Kim, Mary Shago, Lilia Kaustov et al. · Cancer Research · 2007 · 73 citations · Full text

1–5 of 7